Patients' adherence to secondary prevention pharmacotherapy after acute coronary syndromes

International Journal of Clinical Pharmacy

Volumn 35, Issue 2, 2013, Pages 275-280

  Kassab, Yaman ^a   Hassan, Yahaya ^b   Abd Aziz, Noorizan ^b   Ismail, Omar ^c   AbdulRazzaq, Hadeer ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c HOSPITAL PULAU PINANG   (Malaysia)

Author keywords

Acute coronary syndrome; Adherence; Malaysia; Morisky scale; Secondary prevention Medications

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; COMORBIDITY; EMPLOYMENT STATUS; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; OUTPATIENT; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SECONDARY PREVENTION; VERY ELDERLY; AGE; EMPLOYMENT; EVIDENCE BASED MEDICINE; MALAYSIA; METHODOLOGY;

ACUTE CORONARY SYNDROME; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; EMPLOYMENT; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALAYSIA; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSPECTIVE STUDIES; SECONDARY PREVENTION;

EID: 84884479819     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9735-y     Document Type: Article

References (25)

1. Kernis SJ, Harjai KJ, Stone GW, Grines LL, Boura JA, et al. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty? J Am Coll Cardiol. 2004;43: 1773-9.
2. Bhatt DL, Fox KA, Hacke W, Berger PB, Black HR, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Eng J Med. 2006;354: 1706-17.
3. Serruys PC, de Feyter P, Macaya C, Kokott N, Puel J, et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. J Am Med Assoc. 2002;287: 3215-22.
4. Tea KK, Yusuf S, Pfeffer M, Kober L, Hall A, et al. Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet. 2002;360: 1037-43.
5. Ars F, Loma-Osorio A ́, Vila J, Lpez-Bescs L, Cuat J, et al. Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry. Rev Esp Cardiol. 2006;59: 313-20.
6. Spencer FA, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J. 2005;150: 838-44.
7. Sud A, Kline-Rogers EM, Eagle KA, Fang J, Armstrong DF, et al. Adherence to medications by patients after acute coronary syndromes. Ann Pharmacother. 2005;39: 1792-7.
8. Kassab YW, Hassan Y, Abd Aziz N, Akram H, Ismail O. Use of evidence-based therapy for the secondary prevention of acute coronary syndromes in Malaysian practice. J Eval Clin Pract. 2012. doi: 10.1111/j.1365-2753.2012.01894.x.
9. Al-Qasem A, Smith F, Clifford S. Adherence to medication among chronic patients in Middle Eastern countries: review of studies. East Mediterr Health J. 2011;17: 356-63.
10. Gallagher E, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. J Am Med Assoc. 1993;270: 742-4.
11. Ockene I, Hayman L, Pasternak R, Schron E, Dunbar-Jacob J. Task force #4-adherence issues and behavior changes: achieving a long-term solution. J Am Coll Cardiol. 2002;40: 630-40.
12. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27(9 suppl):S1-24.
13. Al-Qazaz HK, Hassali MA, Shafie AA, Sulaiman SA, Sundram S, Morisky DE. The eight-item Morisky Medication Adherence Scale MMAS: translation and validation of the Malaysian version. Diabetes Res Clin Pract. 2010;90: 216-21.
14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10: 348-54.
15. Quek KF, Low WY, Razack AH, Loh CS. Reliability and validity of the International Prostate Symptom Score in a Malaysian population. Brit J Urol. 2001;88: 21-5.
16. Hinton PR, Brownlow C, McMurray I, Cozens B. SPSS Explained. 1st ed. London: Routledge; 2004.
17. Eagle K, Kline-Rogers E, Goodman S, Gurfinkel E, Avezum A, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004;117: 73-81.
18. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, Avorn J. Non-compliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17: 504-11.
19. Eagle KA, Goodman SG, Avezum A ́, Budaj A, Sullivan CM, López-Sendón J. Practice variation and missed opportunities for reperfusion in ST-segment elevation myocardial infarction - findings from the global registry of acute coronary events (GRACE). Lancet. 2002;359: 373-7.
20. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. J Am Med Assoc. 2002;288: 462-7.
21. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. J Am Med Assoc. 2002;288: 455-61.
22. Cheng JWM, Kalis MM, Feifer S. Patient-reported adherence to guidelines of the sixth joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Pharmacotherapy. 2001;21: 828-41.
23. Khanderia U, Townsend KA, Erickson SR, Vlasnik J, Prager RL, Eagle KA. Medication adherence following coronary artery bypass graft surgery: assessment of beliefs and attitudes. Ann Pharmacother. 2008;42: 192-9.
24. Roe CM, Motheral BR, Teitelbaum F, Rich MW. Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm. 2000;57: 139-45.
25. McLane CG, Zyzanski SJ, Flocke SA. Factors associated with medication noncompliance in rural elderly hypertensive patients. Am J Hypertens. 1995;8: 206-9.